|
End-of-day quote
Shenzhen S.E.
30/10/2026
|
5-day change | 1st Jan Change | ||
| 27.66 CNY | -2.33% |
|
-8.62% | -17.56% |
Company Valuation: ApicHope Pharmaceutical Group Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 10,200 | 9,894 | 13,394 | 7,660 | 15,065 | 12,406 | - | - |
| Change | - | -3% | 35.39% | -42.81% | 96.66% | -17.65% | - | - |
| Enterprise Value (EV) | 10,200 | 9,894 | 13,394 | 7,660 | 15,065 | 12,406 | 12,406 | 12,406 |
| Change | - | -3% | 35.39% | -42.81% | 96.66% | -17.65% | 0% | 0% |
| P/E | 33.6x | 36.2x | 71x | -14.3x | -44.9x | 23.8x | -120x | -86.4x |
| PBR | - | 5.12x | 5.37x | 4.1x | - | 6.59x | 6.97x | 7.58x |
| PEG | - | -3.4x | -2.1x | 0x | 1.2x | -0x | 1x | -2.2x |
| Capitalization / Revenue | - | 4.34x | 5.35x | 5.28x | - | 11.5x | 9.86x | 8.39x |
| EV / Revenue | - | 0x | 0x | 0x | - | 11.5x | 9.86x | 8.39x |
| EV / EBITDA | - | 0x | 0x | -0x | - | 13.6x | 65.3x | 66.3x |
| EV / EBIT | - | 0x | 0x | -0x | - | 18.9x | -107x | -73.4x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | 0.1333 | 0.21 | - | - | - | - | - |
| Rate of return | - | 0.58% | 0.7% | - | - | - | - | - |
| EPS 2 | 0.7133 | 0.6373 | 0.42 | -1.196 | -0.7478 | 1.16 | -0.23 | -0.32 |
| Distribution rate | - | 20.9% | 50% | - | - | - | - | - |
| Net sales 1 | - | 2,280 | 2,503 | 1,450 | - | 1,080 | 1,258 | 1,478 |
| EBITDA 1 | - | 369.9 | 389.8 | -94.81 | - | 913 | 190 | 187 |
| EBIT 1 | - | 282 | 213.9 | -370.7 | - | 657 | -116 | -169 |
| Net income 1 | 306.9 | 290.7 | 184.6 | -540 | -337.8 | 526 | -102 | -146 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 23.93 | 23.05 | 29.83 | 17.06 | 33.55 | 27.66 | 27.66 | 27.66 |
| Nbr of stocks (in thousands) | 426,174 | 429,162 | 449,027 | 449,027 | 449,027 | 448,531 | - | - |
| Announcement Date | 4/20/22 A | 4/19/23 A | 4/26/24 A | 4/24/25 A | 4/23/26 A | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 23.84x | - | - | - | 1.86B | |
| 41.54x | 14.06x | 31.11x | 0.48% | 1,263B | |
| 39.99x | 6.71x | 18.89x | 1.95% | 658B | |
| 38.61x | 8.62x | 17.83x | 2.33% | 521B | |
| 21.74x | 5.27x | 13.12x | 2.48% | 391B | |
| 109.15x | 6.06x | 25.73x | 2.28% | 369B | |
| 23.19x | 5.97x | 14.41x | 2.71% | 307B | |
| 24.47x | 4.9x | 13.63x | 1.77% | 290B | |
| 29.56x | 7.53x | 13.48x | 2.16% | 252B | |
| -49.1x | 7.47x | 29.35x | 1.93% | 212B | |
| Average | 30.30x | 7.40x | 19.73x | 2.01% | 426.38B | |
| Weighted average by Cap. | 37.28x | 8.84x | 21.96x | 1.69% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 300723 Stock
- Valuation ApicHope Pharmaceutical Group Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
